Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1138 | SRRK Scholar Rock Holding Corporation - Common Stock | 56.07 USD | -0.76% | +7.60% | +15.30% | +86.78% | 6.83 B USD | ||
| 1185 | COGT Cogent Biosciences, Inc. - Common Stock | 36.28 USD | -1.23% | -4.12% | -9.41% | +131.53% | 6.30 B USD | ||
| 1192 | BLTE Belite Bio Inc - American Depositary Shares | 159.15 USD | -1.19% | -2.26% | +3.12% | +145.60% | 6.26 B USD | ||
| 1199 | MIRM Mirum Pharmaceuticals, Inc. - common stock | 95.71 USD | -0.62% | -4.45% | -16.88% | +36.48% | 6.21 B USD | ||
| 1206 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 109.70 USD | -1.26% | -4.88% | +5.64% | +351.44% | 6.14 B USD | ||
| 1207 | TVTX Travere Therapeutics, Inc. - Common Stock | 64.15 USD | -2.37% | +2.53% | +10.70% | +122.98% | 6.05 B USD | ||
| 1210 | ERAS Erasca, Inc. - Common Stock | 17.17 USD | -2.61% | -6.53% | -11.77% | +986.71% | 6.01 B USD | ||
| 1212 | LQDA Liquidia Corporation - Common Stock | 68.57 USD | -0.07% | -9.43% | -20.44% | +203.41% | 6.14 B USD | ||
| 1230 | DFTX Definium Therapeutics, Inc. - Common Shares | 42.45 USD | -5.48% | -3.63% | -2.75% | +180.94% | 5.70 B USD | ||
| 1240 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.35 USD | -0.69% | -2.05% | -7.93% | +47.95% | 5.84 B USD | ||
| 1251 | PTCT PTC Therapeutics, Inc. - Common Stock | 68.20 USD | -2.32% | -4.89% | -12.14% | +34.68% | 5.69 B USD | ||
| 1260 | CRSP CRISPR Therapeutics AG - Common Shares | 57.20 USD | -3.87% | +7.42% | +20.02% | +5.44% | 5.53 B USD | ||
| 1266 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 281.87 USD | -1.54% | -4.59% | -7.57% | +50.64% | 5.62 B USD | ||
| 1344 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.26 USD | -0.81% | +2.49% | +16.07% | +14.03% | 5.04 B USD | ||
| 1372 | DYN Dyne Therapeutics, Inc. - Common Stock | 25.38 USD | -2.76% | -0.47% | +1.52% | +8.42% | 4.74 B USD | ||
| 1382 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 43.20 USD | -2.22% | -0.32% | +3.85% | +183.65% | 4.69 B USD | ||
| 1418 | CELC Celcuity Inc. - Common Stock | 91.32 USD | -2.36% | -0.72% | +8.57% | +72.56% | 4.47 B USD | ||
| 1449 | ELVN Enliven Therapeutics, Inc. - Common Stock | 59.68 USD | -0.23% | +1.96% | +10.97% | +188.87% | 4.37 B USD | ||
| 1468 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 39.27 USD | +1.58% | +77.61% | +112.27% | +323.17% | 4.38 B USD | ||
| 1477 | RLAY Relay Therapeutics, Inc. - Common Stock | 18.88 USD | -2.88% | -5.93% | +2.22% | +411.65% | 4.14 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |